AstraZeneca CEO Pascal Soriot is considering a move of the company's primary stock listing from London to the U.S., according to British news outlet The Times. (Photo by Zhang Liyun/Xinhua via Getty ...
AstraZeneca CEO Pascal Soriot collected 14.7 million pounds sterling ($18.5 million) in compensation in 2024, down 16% from his 2023 pay of 17.4 million pounds ($21.9 million). (Photo by JUSTIN TALLIS ...
Monday - Friday, 6:00 - 7:00 PM ET In a Tuesday interview with CNBC's Jim Cramer, AstraZeneca CEO Pascal Soriot explained why the drugmaker believes it can almost double revenue by the end of the ...
19don MSN
AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success
AstraZeneca CEO Pascal Soriot said AI is helping the company develop medicines faster and make smarter decisions throughout the research process.
AstraZeneca CEO Pascal Soriot Updates On Chinese Compliance Probe And Lung Cancer Drug Trial Results
Recently, Chinese authorities detained some current and former employees of AstraZeneca Plc (NASDAQ:AZN) as part of a broader investigation into alleged illegal activities in the pharmaceutical sector ...
For most CEOs in the U.K., a salary exceeding $20 million is the stuff of dreams. However, for AstraZeneca’s CEO, it appears to be sparking a battle between those who think his pay packet is excessive ...
The most expensive product in modern business is the one that never ships. Nowhere is that more true than in a pharmaceutical ...
Hosted on MSN
Soriot plays the China card: Astra boss should be careful what he wishes for, says Alex Brummer
Whether in China or the United States, Pascal Soriot knows how to capture headlines. In Washington last year, the chief executive revealed that Britain’s biggest company AstraZeneca would be putting ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that Pascal Soriot, CEO of AstraZeneca, and Judy Gawlik Brown, founder and CEO of Downtown Advisory, have been ...
AstraZeneca $AZN CEO Pascal Soriot is already one of the highest paid pharmaceutical CEOs in Europe. Still, shareholders of the U.K.-based company can’t agree on ...
Hosted on MSN
Britain losing race to make new drugs: AstraZeneca boss blasts UK for deterring investment
The boss of drug giant AstraZeneca has warned that the UK is deterring investment from the pharma industry. Chief executive Pascal Soriot said Britain should be trying to attract cash from the sector ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results